Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in-vitro study

Brunner, Teresa F.; Probst, Florian A.; Troeltzsch, Matthias; Schwenk-Zieger, Sabina; Zimmermann, Julia L.; Morfill, Gregor; Becker, Sven; Harreus, Ulrich; Welz, Christian

dc.contributor.author	Becker, Sven
dc.date.accessioned	2023-01-03T10:35:25Z
dc.date.available	2023-01-03T10:35:25Z
dc.date.issued	2022
dc.identifier.issn	1746-160X
dc.identifier.uri	http://hdl.handle.net/10900/134983
dc.language.iso	en	de_DE
dc.publisher	Bmc	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/s13005-022-00322-5	de_DE
dc.subject.ddc	610	de_DE
dc.title	Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in-vitro study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_00269
utue.personen.roh	Brunner, Teresa F.
utue.personen.roh	Probst, Florian A.
utue.personen.roh	Troeltzsch, Matthias
utue.personen.roh	Schwenk-Zieger, Sabina
utue.personen.roh	Zimmermann, Julia L.
utue.personen.roh	Morfill, Gregor
utue.personen.roh	Becker, Sven
utue.personen.roh	Harreus, Ulrich
utue.personen.roh	Welz, Christian
dcterms.isPartOf.ZSTitelID	Head & Face Medicine	de_DE
dcterms.isPartOf.ZS-Issue	Article 21	de_DE
dcterms.isPartOf.ZS-Volume	18 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE